News

Sobi presents clinical data at WFH 2025 Comprehensive Care Summit
Key data to be presented at WFH 2025 Comprehensive Care Summit, Dubai, UAE Altuvoct® (efanesoctocog alfa) Location: Great Ballroom .
Roche's Susvimo FDA Approval Marks New Era in Diabetic Macular Edema Treatment Market | DelveInsight
Diabetic macular edema is a complication that develops from diabetic retinopathy, a widespread consequence of diabetes and a ...
Swedish Orphan Biovitrum AB: Sobi presents clinical data at WFH 2025 Comprehensive Care Summit
Sobi® (STO: SOBI) presents clinical data aimed at updating the global haemophilia community attending this year's WFH 2025 Comprehensive Care Summit ...
The Cardiology Advisor15d
Sotatercept Reduces Major Events in High-Risk PAH Patients
Sotatercept-csrk reduced the risk of major morbidity and mortality events in adults with WHO Group 1 PAH FC 3 or 4 at high risk of mortality.
The Manila Times on MSN2d
Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution
LONDON, April 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a ...
DelveInsight Business Research, LLP: Roche's Susvimo FDA Approval Marks New Era in Diabetic Macular Edema Treatment Market | DelveInsight
Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include treatment for diabetic macular edema, the primary ...
American Association of Individual Investors7d
Why Tonix Pharmaceuticals Holding Corp.’s (TNXP) Stock Is Up 7.99%
Tonix Pharmaceuticals Holding Corp.’s TNXP share price has surged by 7.99%, which has investors questioning if this is right ...
pharmaphorum2d
Sanofi snaps up Inhibrx and its rare disease drug for $2.2bn
INBRX-101 is a recombinant human AAT-Fc fusion protein designed to replace the enzyme that is deficient in AATD and offer less frequent dosing than current therapies for the disease, based on ...